It is plausible that DUSP16, whose expression is induced by chemotherapeutic agents, targets both JNK and p38 to regulate cancer cell response, and therefore, might be an important target for enhancing the efficacy of chemotherapy. This evidence concerns the gene DUSP16 and cancer.